Clinical Trial Update: Alfuzosin for Treating Acute Urinary Retention [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial evaluating alfuzosin for treating acute urinary retention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Retention

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Acute Urinary Retention | Phase 2 | Status: COMPLETED